GlassScriptPhysician profile
Shiny Jacob
NPI 1700638293
$564.31
in general payments reported to CMS, 2019-2025
11 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $111 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $235.03 | 2024-2025 | Spravato, Invega Sustenna |
| Alkermes, INC. | $97.68 | 2025 | Aristada, Lybalvi |
| Ebr Systems, INC. | $40.53 | 2025 | |
| Neurocrine Biosciences, INC. | $37.65 | 2024 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $29.78 | 2025 | Rexulti |
| Sage Therapeutics, LLC | $29.06 | 2024 | |
| Eisai INC. | $24.13 | 2025 | |
| Luye Pharma (USA) LTD. | $21.72 | 2025 | Erzofri Extended-Release |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.16 | 2025 | Caplyta |
| Noven Therapeutics, LLC | $18.87 | 2025 | Xelstrym |
| Corium, LLC | $10.70 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiny Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.